{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Soluble lymphotoxin-&bgr; receptor as a therapeutic agent for treating TH-1 cell-associated autoimmune disease", "item": "https://www.patentleaderboard.com/patent/6669941"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Soluble lymphotoxin-&bgr; receptor as a therapeutic agent for treating TH-1 cell-associated autoimmune disease

Soluble lymphotoxin-&bgr; receptor as a therapeutic agent for treating TH-1 cell-associated autoimmune disease

US Patent 6669941 · Granted Dec 30, 2003

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-VLA-4 related assays2025
Grid coatings for capture of proteins and other compounds2024
Anti-VLA-4 related assays2022
Grid coatings for capture of proteins and other compounds2021
Methods of modulating immune responses using BCMA polypeptide2019
Anti-VLA-4 related assays2019
Anti-VLA-4 related assays2017
Methods of treating autoimmune diseases using a B-cell maturation antigen (BCMA)2017
Anti-VLA-4 related assays2016
Polymer conjugates of interferon beta-1A and uses2016
Methods of screening for a compound that inhibits the interaction between BAFF a2014
Method for increasing expression of active tumor necrosis factor receptor family2014